FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:948 February 26, 2004 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Hagmann, C. PubMed Citation

To the Editor: In Hagmann and Berger's description of congenital pulmonary lymphangiectasia in Images in Clinical Medicine (Nov. 27 issue),¹ the authors state, "Congenital pulmonary lymphangiectasia . . . is a uniformly fatal disease when it manifests in the newborn period." Having followed several such patients for 12 to 60 months, we disagree with this statement. The authors evidently did not see the report on radiographic findings in children with congenital pulmonary lymphangiectasia who survive infancy.² Much of the literature on congenital pulmonary lymphangiectasia is heavily influenced by early reports that preceded modern care provided in the neonatal intensive care . . . [Full Text of this Article]

This article has been cited by other articles:

• Hoehn, T., William, M., McPhaden, A. R., Stannigel, H., Mayatepek, E., Wadsworth, R. M. (2006). Endothelial, inducible and neuronal nitric oxide synthase in congenital pulmonary lymphangiectasis.. Eur Respir J 27: 1311-1315 [Abstract] [Full Text]